Characterization of niphatenones that inhibit androgen receptor N-terminal domain.

Ngā tūemi rite

• Characterization of niphatenones that inhibit androgen receptor N-terminal domain.
  mā: Carmen A Banuelos, me ētahi atu.
  I whakaputaina: (2014-01-01)
• Combination therapy with androgen receptor N‐terminal domain antagonist EPI‐7170 and enzalutamide yields synergistic activity in AR‐V7‐positive prostate cancer
  mā: Yukiyoshi Hirayama, me ētahi atu.
  I whakaputaina: (2020-10-01)
• Pin1 inhibition improves the efficacy of ralaniten compounds that bind to the N-terminal domain of androgen receptor
  mā: Jacky K. Leung, me ētahi atu.
  I whakaputaina: (2021-03-01)
• Inhibition of androgen receptor by decoy molecules delays progression to castration-recurrent prostate cancer.
  mā: Jae-Kyung Myung, me ētahi atu.
  I whakaputaina: (2017-01-01)
• Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells
  mā: Yeh, Shuyuan, me ētahi atu.
  I whakaputaina: (2000)